TMPRSS2 and posterior cortical atrophy: Compared with serum PSA, the combination of urine PCA3 and fusion gene TMPRSS2-ERG significantly improved the specificity of PCa diagnosis and reduced unnecessary prostate biopsy (Salagierski and Schalken, 2012).